Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for In-process Monitoring and Control during FFS Operations

Posted on By

SOP for In-process Monitoring and Control during FFS Operations

Standard Operating Procedure for In-process Monitoring and Control during FFS Operations

1) Purpose

The purpose of this SOP is to outline the procedures for monitoring and controlling critical parameters during Form-Fill-Seal (FFS) operations to ensure product quality and process efficiency.

2) Scope

This SOP applies to all FFS operations conducted within the pharmaceutical manufacturing facility.

3) Responsibilities

3.1 Production Operators

  • Monitor FFS machine operation and critical parameters as per defined procedures.
  • Take corrective actions as necessary to maintain process control and product quality.

3.2 Quality Assurance (QA) Personnel

  • Review in-process monitoring data and verify compliance with specifications.
  • Investigate deviations and implement corrective and preventive actions (CAPA) as required.
See also  SOP for Bioburden Testing

4) Procedure

4.1 Setup and Preparation

  1. Ensure FFS machine is set up and calibrated according to approved procedures.
  2. Verify availability of raw materials and packaging components for the operation.

4.2 In-process Monitoring

  1. Monitor critical process parameters such as temperature, pressure, and fill volume during FFS operations.
  2. Record monitoring data at specified intervals or events as per batch records.

4.3 Control Measures

  1. Take immediate corrective actions in case of deviations from specified limits or conditions.
  2. Notify relevant personnel (e.g., supervisors, QA) and document actions taken.

4.4 Documentation and Reporting

  1. Document in-process monitoring activities, including deviations and corrective actions.
  2. Report any significant deviations or trends to QA and initiate investigation if necessary.
See also  SOP for Change Control in Manufacturing Processes

5) Abbreviations, if any

FFS: Form-Fill-Seal
QA: Quality Assurance
CAPA: Corrective and Preventive Action

6) Documents, if any

  • In-process Monitoring Records
  • Batch Records
  • Deviation Reports

7) Reference, if any

ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
FDA Guidance for Industry: Process Validation: General Principles and Practices

8) SOP Version

Version 1.0

Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

Post navigation

Previous Post: SOP for Emergency Maintenance Procedures
Next Post: SOP for HVAC System Monitoring

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version